Insider Trading & Ownership - UBS Oncology Impact Fund L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for UBS Oncology Impact Fund L.P.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-01-04
Sale
2022-01-06
4:12 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
245,469$42.58$10,452,3344,484,728
(Indirect)
View
2021-12-03
Sale
2021-12-07
6:33 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
83,390$33.73$2,812,4284,730,197
(Indirect)
View
2021-11-30
Sale
2021-12-02
6:53 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
139,773$34.47$4,817,4174,813,587
(Indirect)
View
2021-11-26
Sale
2021-11-30
4:49 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
38,566$35.18$1,356,8254,953,360
(Indirect)
View
2021-11-22
Sale
2021-11-24
6:38 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
129,617$36.61$4,744,6665,007,597
(Indirect)
View
2021-10-15
Sale
2021-10-18
4:33 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
28,615$27.45$785,3845,137,214
(Indirect)
View
2021-10-12
Sale
2021-10-14
5:26 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
95,002$27.21$2,584,6065,165,829
(Indirect)
View
2021-10-07
Sale
2021-10-12
4:33 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
87,006$27.23$2,368,8005,260,831
(Indirect)
View
2021-10-01
Sale
2021-10-05
4:31 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
46,130$27.05$1,247,5905,347,837
(Indirect)
View
2021-09-28
Sale
2021-09-30
5:05 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
35,990$27$971,7305,393,967
(Indirect)
View
2021-09-23
Sale
2021-09-27
5:51 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
89,476$27.76$2,484,0945,429,957
(Indirect)
View
2021-09-21
Sale
2021-09-23
4:18 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
56,779$27.5$1,561,3945,519,433
(Indirect)
View
2021-09-16
Sale
2021-09-20
6:30 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
152,711$28.38$4,334,4525,576,212
(Indirect)
View
2021-09-16
Sale
2021-09-20
5:31 pm
Cullinan Oncology Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
BioImpact Capital LLC
10% Owner
3,124$29.06$90,7837,648,268
(Direct)
View
2021-09-14
Sale
2021-09-16
4:46 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
76,417$27.7$2,116,7335,728,923
(Indirect)
View
2021-09-14
Sale
2021-09-16
4:45 pm
Cullinan Oncology Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
BioImpact Capital LLC
10% Owner
13,531$29.17$394,6357,651,392
(Direct)
View
2021-09-09
Sale
2021-09-13
7:02 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
96,456$28.32$2,731,4605,805,340
(Indirect)
View
2021-09-09
Sale
2021-09-13
6:24 pm
Cullinan Oncology Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
BioImpact Capital LLC
10% Owner
23,253$29.23$679,7387,664,923
(Direct)
View
2021-09-07
Sale
2021-09-08
7:19 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
71,232$29.03$2,067,7865,933,136
(Indirect)
View
2021-09-03
Sale
2021-09-08
6:20 pm
Cullinan Oncology Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
BioImpact Capital LLC
10% Owner
48,640$29.2$1,420,3947,688,176
(Direct)
View
2021-08-31
Sale
2021-09-02
5:26 pm
Cullinan Oncology Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
BioImpact Capital LLC
10% Owner
24,309$29.5$717,2187,736,816
(Direct)
View
2021-08-27
Sale
2021-08-31
4:47 pm
Cullinan Oncology Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
BioImpact Capital LLC
10% Owner
44,358$29.24$1,296,8847,761,125
(Direct)
View
2021-08-23
Sale
2021-08-25
7:42 pm
Cullinan Oncology Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
105,894$29.29$3,101,3447,805,483
(Direct)
View
2021-08-11
Sale
2021-08-12
4:55 pm
Cullinan Oncology Inc.CGEMUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
2,510$29.05$72,9167,911,377
(Direct)
View
2021-05-28
Sale
2021-06-02
6:09 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
57,494$20.63$1,186,1906,328,095
(Indirect)
View
2021-05-26
Sale
2021-05-27
7:40 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
17,159$20.22$346,9386,385,589
(Indirect)
View
2021-05-21
Sale
2021-05-24
8:11 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
15,907$20.18$321,0306,402,748
(Indirect)
View
2021-05-18
Sale
2021-05-20
7:20 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
47,948$20.49$982,2276,418,655
(Indirect)
View
2021-05-13
Sale
2021-05-17
5:23 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
16,421$20.05$329,3146,466,603
(Indirect)
View
2021-05-10
Sale
2021-05-12
6:09 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
68,262$21.04$1,436,5566,483,024
(Indirect)
View
2021-05-04
Purchase
2021-05-06
4:19 pm
Werewolf Therapeutics Inc.HOWLGADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
245,000$16$3,920,0006,672,183
(Indirect)
View
2021-05-05
Sale
2021-05-06
4:05 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
10,172$22.52$229,1076,551,286
(Indirect)
View
2021-04-30
Sale
2021-05-04
5:43 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
328,519$22.48$7,386,4356,561,458
(Indirect)
View
2021-04-27
Sale
2021-04-29
5:46 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
130,143$21.99$2,861,3686,889,977
(Indirect)
View
2021-04-21
Sale
2021-04-22
4:04 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
8,972$18.97$170,2297,020,120
(Indirect)
View
2021-04-16
Sale
2021-04-20
6:07 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
38,152$19.04$726,5507,029,092
(Indirect)
View
2021-04-13
Sale
2021-04-15
8:00 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
38,556$20.16$777,3597,067,244
(Indirect)
View
2021-04-09
Sale
2021-04-13
4:15 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
10% Owner
200$29.99$5,9986,004,368
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-01
Other
2023-06-05
4:37 pm
N/A
N/A
TCR2 THERAPEUTICS INC.TCRRUBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
BioImpact Capital LLC
10% Owner
3,370,982$03,370,982
(Direct)
View
2021-11-17
Other
2021-11-24
6:38 pm
N/A
N/A
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
15,671$05,007,597
(Indirect)
View
2021-09-07
Other
2021-09-08
7:19 pm
N/A
N/A
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
31,340$05,933,136
(Indirect)
View
2021-05-04
Conversion
2021-05-06
4:19 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLGADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
57,683,698$06,672,183
(Indirect)
View

Ownership
2021-04-29
5:31 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLGADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
0$06,486,087
(Indirect)
View
Goto 0, 1, Next